Incyte Corp. sues Padagis Israel Pharmaceuticals in District of New Jersey
Case Summary
Incyte Corporation filed a lawsuit against Padagis Israel Pharmaceuticals in the District of New Jersey, docket number 23-cv-21826. The complaint initiates a civil dispute likely involving intellectual property or commercial issues between pharmaceutical companies.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Key Issues
- • Commercial litigation
- • Pharmaceutical industry
- • Intellectual property
Docket Snapshot
Court
D.N.J.
District of New Jersey · 3rd Circuit · NJ
Docket
Not captured
Civil
Stage
Active litigation
Active
Filed
Date unavailable
Not in the available feed
Latest Filing
2:23-cv-21826 INCYTE CORP. et al v. PADAGIS ISRAEL PHARMACEUTICALS LTD.
Other · Apr 29, 2026
Coverage
1 article
1 source tracked
Participants
1 Defendant, 1 Plaintiff
2 linked entities
Judge
Not assigned in feed
What the record shows
This case is tied to District of New Jersey, a federal district court in NJ.
The newest docket activity we have is a other dated April 29, 2026.
The visible party/entity graph currently includes Padagis Israel Pharmaceuticals Ltd, INCYTE CORP.
Press monitoring has found 1 related article from 1 distinct source.
The Story So Far
INCYTE CORP. et al v. PADAGIS ISRAEL PHARMACEUTICALS LTD. is an active civil matter in District of New Jersey under docket 23-cv-21826.
The dispute currently identifies 2:23-cv-21826 INCYTE CORP on one side and PADAGIS ISRAEL PHARMACEUTICALS LTD on the other. Juryvine classifies the matter around civil litigation, federal courts.
The available docket gives enough signal to track the case, but not enough to overstate the merits. This page will become more useful as filings, orders, hearings, and party appearances add detail.
On April 29, 2026, the docket recorded a other: Incyte Corp. and its affiliates filed a lawsuit against Padagis Israel Pharmaceuticals Ltd. in the U.S.
District Court for the Southern District of Florida. The lawsuit alleges that Padagis engaged in anticompetitive conduct in the market for a specific.
The next thing to watch is whether the latest other produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.
About This Court
District of New Jersey (D.N.J.) is a federal district court in the 3rd Circuit, NJ.
Case Timeline
1 event2:23-cv-21826 INCYTE CORP. et al v. PADAGIS ISRAEL PHARMACEUTICALS LTD.
Incyte Corp. and its affiliates filed a lawsuit against Padagis Israel Pharmaceuticals Ltd. in the U.S. District Court for the Southern District of Florida. The lawsuit alleges that Padagis engaged in anticompetitive conduct in the market for a specific medication. The case is ongoing.
Press Coverage
settings_backup_restore Data provenance expand_more
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
2 days ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.